A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma

Author: Kefford Richard   Beith Jane   Hazel Guy   Millward Michael   Trotter James   Wyld David   Kusic Rada   Shreeniwas Revati   Morganti Adele   Ballmer Andrea   Segal Eleonor   Nayler Oliver   Clozel Martine  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.25, Iss.3, 2007-06, pp. : 247-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content